Lipid-lowering drugs.
D002482:Cellulose / Q000627:therapeutic use; D002792:Cholestyramine Resin / Q000009:adverse effects / Q000627:therapeutic use*; D002994:Clofibrate / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D006801:Humans; D006949:Hyperlipidemias / Q000178:diet therapy / Q000188:drug therapy*; D008055:Lipids / Q000097:blood; D009203:Myocardial Infarction / Q000097:blood / Q000401:mortality / Q000517:prevention & control*; D009355:Neomycin / Q000009:adverse effects / Q000627:therapeutic use*; D009539:Nicotinic Acids / Q000009:adverse effects / Q000627:therapeutic use*
D008055:Lipids; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D002482:Cellulose; D002994:Clofibrate; D009355:Neomycin